相关实验视频
Updated: Jan 29, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
在骨关节炎临床试验中,使用剂量反应相关性再分析来区分安慰剂与标准化腰粉 (Lito) 在一项临床试验中,数据最初看起来完全相同
Alzahraa Mahmoud Motawei1, Kristian Marstrand Warholm2, Kaj Winther3
1Food Sciences, Faculty of Agriculture, Mansoura University, Mansoura 35516, Egypt.
Nutrients
|January 28, 2026
概括
一种新的剂量反应相关性方法揭示了Rosa-canina (腿) 对骨关节炎的益处,克服了临床试验中经常见到的安慰剂效应. 这项分析确定了标准比较无法检测到的真正的治疗效应.
科学领域:
- 营养科学 营养科学
- 临床试验方法论 临床试验方法论
- 骨关节炎研究 骨关节炎研究
背景情况:
- 临床试验中的安慰剂反应可能会掩盖真正的治疗效果,特别是在新食物等干预措施中.
- 标准的组间比较可能缺乏敏感性,当安慰剂的改善是显著的.
- 在骨关节炎 (OA) 试验中评估粉状Rosa-canina水果,由于潜在的安慰剂效应,提出了挑战.
研究的目的:
- 证明一种剂量反应相关性方法,以区分真正的治疗效应与安慰剂反应.
- 重新分析一项随机对照试验中使用Rosa-canina粉末治疗部和膝关节OA的数据.
- 为了确定罗莎-卡尼娜是否对OA症状表现出剂量依赖的影响.
主要方法:
- 一个多中心,双盲,随机,安慰剂对照试验 (N=120) 的二次分析,用于部和膝盖OA.
- 计算剂量/公斤和WOMAC疼痛/功能的变化之间的皮尔森相关性,在活体和安慰剂组的6周和12周.
- 剂量反应相关性分析与标准组间比较的比较.
主要成果:
- 活体和安慰剂组都显示了WOMAC疼痛和功能的>50%改善,两组之间没有显著差异.
- 罗莎-卡尼纳组在体重和症状改善之间呈现负相关性 (剂量/千克较高,益处更大).
- 在安慰剂组中没有观察到剂量反应关系,这表明Rosa-canina的真正作用.
结论:
- 剂量反应相关性分析确定了罗莎-卡尼纳作为营养素的积极影响,标准比较无法检测到.
- 这种方法有效地区分了活跃治疗效应和安慰剂反应在有显著非特异性改善的试验中.
- 这些发现支持Rosa-canina的有效性,并表明这种分析方法可以改善生物活性营养素的识别,并指导未来的研究.
相关概念视频
Statistical Software for Data Analysis and Clinical Trials
1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
Clinical Trials
10.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.4K
Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Correlation of Experimental Data
481
Dimensional analysis simplifies complex physical problems and guides experimental investigations, but it does not provide complete solutions. It identifies the dimensionless groups that influence a phenomenon, but experimental data is needed to establish the specific relationships and validate theoretical predictions.
For example, a spherical particle moving through a viscous fluid experiences drag. Dimensional analysis shows that the drag force depends on the particle's diameter, velocity,...
For example, a spherical particle moving through a viscous fluid experiences drag. Dimensional analysis shows that the drag force depends on the particle's diameter, velocity,...
481
Dose-Response Relationship: Overview
5.0K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.0K

